UPM Institutional Repository

Efficacy of riboflavin/UVA treatment in modulating Candida tropicalis growth and cytokine profiles in the systemic candidiasis murine model


Citation

Nuratiqah, Farah and Lim, Chee Woei and Chin, Voon Kin and Chong, Pei Pei and Rusliza, Basir and Huzlinda, Hussin and Lee, Tze Yan (2026) Efficacy of riboflavin/UVA treatment in modulating Candida tropicalis growth and cytokine profiles in the systemic candidiasis murine model. Microbial Pathogenesis, 215. art. no. 108454. pp. 1-17. ISSN 0882-4010; eISSN: 1096-1208

Abstract

Candidiasis, particularly from non-albicans Candida (NAC) species appealed as a global burden with high mortality in immunocompromised individuals. The biofilm formation aptitude of the Candida species has escalated the development of drug resistance in clinical settings, rendering it more difficult to treat candidiasis. Previous studies have shown that riboflavin in combination with UVA light poses candidacidal activity; however, its biological basis remains elusive. Thus, this study sought to investigate the antifungal activity and host immune response of UVA-photoactivated riboflavin against a systemic C. tropicalis infection in a mouse model. Downstream analyses at two time points, day 3 and 7, demonstrated that riboflavin and riboflavin/UVA treatments resulted in partial organ-specific reduction in fungal burden across organs and influenced haematological parameters. The interventions also has modulated host immune response, as evidenced by a downregulation of both pro-inflammatory and anti-inflammatory cytokines by day 7. The histopathological assessment revealed persistent inflammatory aggregates and invasion of yeast and pseudohyphae in the kidney tissue. The present data unveils that riboflavin and UVA-photoactivated riboflavin demonstrated partial antifungal efficacy and the ability to modulate the host immune response locally and systemically. Although these interventions reduced fungal burden in several organs, complete clearance was not achieved in the kidneys, where persistent fungal invasion and inflammation remained. These findings suggest that riboflavin-based photodynamic therapy holds potential as a supplemental therapeutic strategy, though further optimization is required to address deep-seated renal pathogenesis.


Download File

[img] Text
124696.pdf - Published Version
Restricted to Repository staff only

Download (16MB)

Additional Metadata

Item Type: Article
Subject: Microbiology
Subject: Infectious Diseases
Divisions: Faculty of Medicine and Health Science
DOI Number: https://doi.org/10.1016/j.micpath.2026.108454
Publisher: Academic Press
Keywords: Candidiasis; Host immunomodulation; Riboflavin/uva; Systemicc. tropicalisinfection
Sustainable Development Goals (SDGs): SDG 3: Good Health and Well-being, SDG 17: Partnerships for the Goals, SDG 9: Industry, Innovation and Infrastructure
Depositing User: Ms. Siti Radziah Mohamed@mahmod
Date Deposited: 24 Jun 2026 01:57
Last Modified: 24 Jun 2026 01:57
Altmetrics: https://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.1016/j.micpath.2026.108454
URI: http://psasir.upm.edu.my/id/eprint/124696
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item